LEBWOHL DAVID (EVP, Chief Medical Officer) sold 9.8% of their position (9.56K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $116.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2025ACC: 0000950170-25-003015
Officer· EVP, Chief Medical Officer
Since Apr 2020
-9.56K
Net shares
Net seller
$116.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.56K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.56K
Price / share
$12.18
Trade value
$116.40K
% of position
9.8%
1/3/2025
97.22K→87.67K
Total
Net shares
−9.56K
Net value
-$116.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | S · Sale | −9.56K | $12.18 | $116.40K | 9.8% | 97.22K | 87.67K |
| Total | −9.56K | -$116.40K | ||||||
Derivative Transactions0
No derivative transactions reported